Cite

    Ratner, R. et al. (n.d.). Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre‐planned meta‐analysis of phase 3 trials. Diabetes, obesity & metabolism. 15 (2), pp. 175-184. [Online].